|
Originally published In Press as doi:10.1074/jbc.M110235200 on December 27, 2001
J. Biol. Chem., Vol. 277, Issue 10, 8226-8234, March 8, 2002
Phosphatidylinositol 3-Kinase Controls Human Intestinal
Epithelial Cell Differentiation by Promoting Adherens Junction Assembly
and p38 MAPK Activation*
Patrick
Laprise ,
Pierre
Chailler,
Mathieu
Houde,
Jean-François
Beaulieu,
Marie-Josée
Boucher, and
Nathalie
Rivard§
From the Canadian Institutes of Health Research Group on Functional
Development and Physiopathology of the Digestive Tract,
Département d'Anatomie et Biologie Cellulaire, Faculté de
Médecine, Université de Sherbrooke, Sherbrooke,
Québec J1H 5N4, Canada
Received for publication, October 24, 2001, and in revised form, December 21, 2001
 |
ABSTRACT |
The signaling pathways mediating human intestinal
epithelial cell differentiation remain largely undefined.
Phosphatidylinositol 3-kinase (PI3K) is an important modulator of
extracellular signals, including those elicited by E-cadherin-mediated
cell-cell adhesion, which plays an important role in maintenance of the
structural and functional integrity of epithelia. In this study, we
analyzed the involvement of PI3K in the differentiation of human
intestinal epithelial cells. We showed that inhibition of PI3K
signaling in Caco-2/15 cells repressed sucrase-isomaltase and villin
protein expression. Morphological differentiation of enterocyte-like
features in Caco-2/15 cells such as epithelial cell polarity and
brush-border formation were strongly attenuated by PI3K inhibition.
Immunofluorescence and immunoprecipitation experiments revealed that
PI3K was recruited to and activated by E-cadherin-mediated cell-cell
contacts in confluent Caco-2/15 cells, and this activation appears to
be essential for the integrity of adherens junctions and association
with the cytoskeleton. We provide evidence that the assembly of
calcium-dependent adherens junctions led to a rapid and
remarkable increase in the state of activation of Akt and p38 MAPK
pathways and that this increase was blocked in the presence of
anti-E-cadherin antibodies and PI3K inhibitor. Therefore, our results
indicate that PI3K promotes assembly of adherens junctions, which, in
turn, control p38 MAPK activation and enterocyte differentiation.
 |
INTRODUCTION |
The epithelium of the small intestine is characterized
by its rapid and constant renewal. This process involves cell
generation and migration from the stem cell population located at the
bottom of the crypt to the extrusion of terminally differentiated cells at the tip of the villus (1). Thus, the crypt is mainly composed of
proliferative and poorly differentiated cells, whereas the villus is
lined with functional absorptive, goblet, and endocrine cells (1). The
molecular and cellular mechanisms responsible for the fine coordination
between proliferation, migration, and differentiation along the
crypt-villus axis are still largely unknown.
E-cadherin-mediated cell-cell attachment plays an important role in the
differentiation, polarization, and homeostasis of many epithelia
(2-4). Cadherins are responsible for cell-cell adhesion through a
calcium-dependent interaction of their extracellular domains. Their cytoplasmic tails are linked to the cytoskeleton through
a complex of proteins that includes -, -, and -catenins. This
link is involved in the strengthening of cell-cell adhesion and in the
cohesion of epithelial tissues (5). The importance of cadherins in the
renewal of the intestinal epithelium has been demonstrated in
vivo in two mouse models. Overexpression of E-cadherin in the
crypts of the small intestine reduces cell proliferation and migration
(6). Conversely, expression of a dominant-negative N-cadherin leads to
over-proliferation, uncoordinated differentiation, and a Crohn's
disease phenotype (7).
The intracellular signaling pathways that transmit extracellular cues
for epithelial differentiation along the crypt-villus axis of the
intestine remain poorly defined. We recently reported that p38
MAPK1 plays a crucial role in
intestinal epithelial cell differentiation by enhancing the
transactivation capacity of CDX2 (8), an intestine-specific homeobox
gene product well known for its broad effect on enterocyte differentiation (9). However, the upstream signaling pathways activating p38 MAPK in committed intestinal cells induced to
differentiate remain to be defined. Interestingly, in vitro
experiments have shown that the establishment of cell-cell contacts in
intestinal cell cultures could be a critical step in initiating p38
MAPK action (8), cell cycle arrest (10, 11), and induction of the
differentiation process (8, 12-15).
An important role for p38 MAPK in various mammalian cell
differentiation processes has recently been proposed (16). For instance, differentiation of C2C12 and L8 myoblasts into myotubes has
been found to be mediated by p38 activation (17, 18). Although this
skeletal muscle differentiation requires phosphatidylinositol 3-kinase
(PI3K), it is not yet clear whether PI3K and p38 MAPK act in a common
pathway (19, 20). The PI3K family members are lipid kinases that
phosphorylate phosphoinositides at position 3 of the inositol ring
(21), acting as membrane anchors that locate and activate pleckstrin
homology domain-containing effectors such as the well characterized
serine/threonine kinase Akt (22). Class I PI3Ks are generally composed
of a p85 regulatory subunit and a p110 catalytic subunit (21). This
class of PI3Ks can be activated by a wide variety of extracellular
stimuli, including those elicited by E-cadherin-mediated cell-cell
adhesion (23).
In this study, the role and regulation of PI3K in intestinal epithelial
cells were investigated. Using several approaches, we demonstrated that
PI3K is necessary for the functional and morphological differentiation
of intestinal epithelial cells. We also found that PI3K is recruited to
and activated by E-cadherin-mediated cell-cell contacts in confluent
Caco-2/15 cultures and that this activation appears to be essential for
the integrity of the adherens junctions and the association of their
components with the cytoskeleton. Finally, we have provided evidence
that the assembly of the adherens junctions stimulates Akt and p38 MAPK
in a PI3K-dependent manner.
 |
EXPERIMENTAL PROCEDURES |
Materials--
[ -32P]ATP and the enhanced
chemiluminescence immunodetection system (ECL) were obtained from
Amersham Biosciences, Inc. (Baie d'Urfé, Québec, Canada).
Antiserum that specifically recognizes p38 MAPK on Western
blots (24) was a kind gift from Dr. J. Landry (Université Laval,
Laval, Québec). Monoclonal antibody HSI-14 (25) against
sucrase-isomaltase was kindly provided by Dr. A. Quaroni (Cornell
University, Ithaca, NY). Monoclonal antibody CII10 recognizing the
89-kDa apoptotic fragment and the 113-kDa non-cleaved fragment of
poly(ADP-ribose) polymerase was a kind gift from Dr. G. G. Poirier
(Université Laval). Fluorescein isothiocyanate-labeled goat anti-rabbit IgG and rhodamine-labeled goat anti-mouse IgG were
from Roche Molecular Biochemicals (Laval). Antibodies raised against
villin, E-cadherin (used in Western blotting and immunofluorescence), and -catenin were purchased from Transduction Laboratories
(Mississauga, Ontario, Canada). Antibody recognizing the phosphorylated
and active form of p38 MAPK was from Promega (Nepean, Ontario).
Antibody directed against the PI3K p85 regulatory subunit was obtained from Upstate Biotechnology, Inc. (Lake Placid, NY). Anti-Akt and anti-phospho-Akt(Ser473) antibodies were purchased from
Cell Signaling (Mississauga). Antibody directed against total actin was
from Roche Molecular Biochemicals. The anti-ZO-1 antibody and the
anti-E-cadherin antibody used in antibody inhibition experiments were
from Zymed Laboratories Inc. (South San Francisco,
CA). The specific inhibitor of PI3K (LY294002) was purchased from
Calbiochem (Mississauga). All other materials were obtained from Sigma
(Oakville, Ontario) unless otherwise stated.
Cell Culture--
The Caco-2/15 cell line was obtained from Dr.
A. Quaroni. This clone of the parent Caco-2 cell line (HTB37; American
Type Culture Collection, Manassas, VA) has been extensively
characterized elsewhere (13, 15, 26) and was originally selected for
expressing the highest level of sucrase-isomaltase among 16 clones
obtained by random cloning. This cell line was routinely cultured in
plastic dishes in Dulbecco's modified Eagle's medium
(Invitrogen, Burlington, Ontario) containing 10% fetal bovine
serum, 4 mM glutamine, 20 mM HEPES, 50 units/ml
penicillin, and 50 µg/ml streptomycin. Caco-2/15 cells were used
between passages 53 and 78. Studies were performed on cultures at
subconfluence (50%) and confluence and between days 2 and 15 post-confluence.
Protein Expression and Immunoblotting--
Cells were lysed in
SDS sample buffer (62.5 mM Tris-HCl (pH 6.8), 2.3% SDS,
10% glycerol, 5% -mercaptoethanol, and 0.005% bromphenol blue).
Proteins (10-50 µg) from whole cell lysates were separated by
SDS-PAGE on 7.5 or 10% gels. Proteins were detected immunologically
following electrotransfer onto nitrocellulose membranes (Amersham
Biosciences, Inc.). Protein and molecular mass markers (Bio-Rad,
Mississauga) were revealed by Ponceau red staining. Membranes were
blocked in PBS containing 5% powdered milk and 0.05% Tween 20 for at
least 1 h at 25 °C. Membranes were then incubated overnight at
4 °C with primary antibodies in blocking solution and then with
horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit IgG
(1:1000) for 1 h. The blots were visualized using the Amersham
Biosciences ECL system. Protein concentrations were measured using a
modified Lowry procedure with bovine serum albumin as the
standard (27).
Expression Vectors and Reporter Constructs--
The
sucrase-isomaltase reporter construct (provided by Dr.
P. G. Traber, University of Pennsylvania, Philadelphia) used for luciferase assays contained the human sucrase-isomaltase promoter from
residues 183 to +54 cloned upstream of the luciferase gene of the
pGL2 reporter construct as described previously (9). The
pRL-SV40 Renilla luciferase vector was from Promega.
Expression vectors for a constitutively active form of PI3K (p110*) and
a dominant-negative form of PI3K ( p85) were obtained from Dr. Julian Downward (Imperial Cancer Research Fund, London, United Kingdom) and
Dr. Masato Kasuga (Kobe University School of Medicine, Kobe, Japan).
Green fluorescent protein (GFP) (CLONTECH, Palo
Alto, CA) was subcloned into the expression vector pLHCX (CLONTECH).
Transient Transfections--
Newly confluent Caco-2/15 cells
grown on glass coverslips in six-well plates were cotransfected by
lipofection (LipofectAMINE 2000, Invitrogen) with 0.5 µg of pLHCX-GFP
and 0.5 µg of pcDNA3 containing or not the dominant-negative form
of PI3K ( p85). Two days following transfection, cells were fixed for
GFP fluorescence and immunofluorescence with either anti-E-cadherin
antibody or anti-total actin antibody.
Luciferase Assays--
Confluent Caco-2/15 cells grown in
24-well plates were transfected by lipofection (LipofectAMINE 2000) as
described previously (15) with 0.1 µg of
sucrase-isomaltase/luciferase reporter. One day following
transfection, cells were treated with 0, 1, 2, 5, 10, and 20 µM LY294002 for 24 h, and luciferase activity was
measured. In other experiments, the sucrase-isomaltase reporter gene
vector was cotransfected with 0.1 µg of pcDNA3 containing or not
the dominant-negative ( p85) or constitutively active (p110*) form of
PI3K. Luciferase activity was measured 36 h after transfection. The pRL-SV40 Renilla luciferase vector was used as a control
for transfection efficiency.
Electron Microscopy--
Cell cultures were rinsed with PBS,
prefixed for 15 min with a 1:1 mixture of culture medium (Dulbecco's
modified Eagle's medium) and freshly prepared 2.8% glutaraldehyde in
cacodylate buffer (0.1 M cacodylate and 7.5% sucrose), and
then fixed for 30 min with 2.8% glutaraldehyde at room temperature.
After two rinses, specimens were post-fixed for 60 min with 2% osmium
tetroxide in cacodylate buffer. The cells were then dehydrated using
increasing ethanol concentrations (40, 70, 90, 95, and 100%; three
times each) and covered twice for 3 h with a thin layer of
Araldite 502 resin (for ethanol substitution). Finally, the resin was
allowed to polymerize at 60 °C for 48 h. The specimens were
detached from the plastic vessels, inverted in embedding molds, covered
with Araldite 502, and reincubated at 60 °C for 48 h. Thin
sections were prepared using an ultramicrotome, contrasted with lead
citrate and uranyl acetate, and observed in a blind fashion on a Jeol 100 CX transmission electron microscope. All reagents were purchased from Electron Microscopy Sciences (Cedarlane, Hornby, Ontario).
Isolation of Cytoskeleton-associated Proteins--
First, the
cells were washed twice with ice-cold PBS, and then soluble proteins
were extracted on ice with cold lysis/cytoskeleton stabilization buffer
(0.5% Triton X-100, 50 mM NaCl, 10 mM PIPES (pH 6.8), 300 mM sucrose, and 3 mM
MgCl2). The cytoskeleton-associated proteins (insoluble
fraction) were harvested by centrifugation (13,000 rpm at 4 °C for
20 min) and solubilized in SDS buffer (15 mM Tris (pH 7.5),
5 mM EDTA, 2.5 mM EGTA, and 1% SDS) (28). Finally, E-cadherin and -catenin levels were determined by
immunoblotting of the cytoskeleton and total fractions (equal amounts
of the soluble and cytoskeleton fractions).
Co-immunoprecipitation Experiments--
Cells were washed twice
with ice-cold PBS and lysed in chilled lysis buffer (150 mM
NaCl, 1 mM EDTA, 40 mM Tris (pH 7.6), 1%
Triton X-100, 0.1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 1 µg/ml pepstatin, 10 µg/ml aprotinin, 0.1 mM orthovanadate, and 40 mM
-glycerophosphate). Cell lysates were then cleared of cellular
debris by centrifugation. Primary antibodies were added to 600 µg of
each cell lysate and incubated for 2 h at 4 °C under agitation.
Forty µg of protein A-Sepharose (Amersham Biosciences, Inc.) were
subsequently added for 1 h (4 °C under agitation).
Immunocomplexes were then harvested by centrifugation and washed four
times with ice-cold lysis buffer. Proteins were solubilized with
Laemmli buffer and separated by SDS-PAGE.
Immunofluorescence Microscopy--
Caco-2/15 cells grown on
sterile glass coverslips were washed twice with ice-cold PBS. Cultures
were then fixed with 30% methanol and 70% acetone for 15 min
at 20 °C, permeabilized with a solution of 0.1% of Triton X-100
in PBS for 10 min, and blocked with PBS and 2% bovine serum albumin
for 20 min at room temperature. Cells were finally immunostained for
1 h with the primary antibody and for 30 min with the secondary
antibody. For F-actin staining, fixed cells were incubated with 1 µg/ml fluorescein isothiocyanate-phalloidin for 30 min. For total
actin staining, fixed cells were incubated with antibody raised against
total actin and then with rhodamine-labeled goat anti-mouse IgG.
Negative controls (no primary antibody) were included in all experiments.
p38 MAPK Assay--
Cells were lysed for 10 min on ice with 1 ml/dish lysis buffer (150 mM NaCl, 1 mM EDTA,
40 mM Tris (pH 7.60), and 1% Triton X-100) supplemented
with protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 1 µg/ml pepstatin, and 10 µg/ml aprotinin) and phosphatase inhibitors (0.1 mM orthovanadate
and 40 mM -glycerophosphate). p38 MAPK was
immunoprecipitated from 400 µg of cell lysate. Immunocomplexes were
then washed four times with ice-cold lysis buffer and three times with
ice-cold kinase buffer (20 mM p-nitrophenyl
phosphate, 10 mM MgCl2, 1 mM
dithiothreitol, and 30 mM HEPES (pH 7.4)) prior to the
kinase assay. The kinase reaction was initiated by incubating the
immunocomplexes at 30 °C in the presence of myelin basic protein and
[ -32P]ATP at 2 µg and 2 µCi/assay, respectively.
After 30 min, the reaction was stopped by adding Laemmli buffer.
Radiolabeled substrates were separated from immunocomplexes by
SDS-12.5% PAGE and autoradiographed. Incorporation of 32P
by myelin basic protein was linear over the course of the kinase assay.
Inhibition of E-cadherin-mediated Cell-Cell Contacts--
Day 2 post-confluent Caco-2/15 cells were serum-starved for 16 h in
Dulbecco's modified Eagle's medium supplemented with 20 mM HEPES, 50 units/ml penicillin, 50 µg/ml streptomycin,
and 4 mM glutamine. The adherens junctions were then
disrupted by treatment with 4 mM EGTA for 30 min at
37 °C. Intercellular contacts were subsequently allowed to
re-establish by restoration of the extracellular calcium concentration
by replacing the EGTA-containing medium with fresh medium (1.8 mM CaCl2) (23, 29). In some experiments, the
fresh medium contained 100 µg/ml anti-E-cadherin antibody or mouse
IgG purified from nonimmune serum. After selected time intervals of
calcium restoration, cells were washed twice with ice-cold PBS and
lysed to detect phospho-Akt and to assay p38 MAPK activity or were
fixed for immunofluorescence.
 |
RESULTS |
PI3K Activity Is Essential for Differentiation of Intestinal
Epithelial Cells--
To investigate the role of PI3K in intestinal
epithelial cell differentiation, we evaluated the impact of its
inhibition on the spontaneous enterocytic differentiation of the human
colon cancer cell line Caco-2/15. This cell line provides a unique and well characterized model for the study of intestinal epithelial differentiation because these cells undergo differentiation to a small
bowel-like phenotype with microvilli, dome formation, and the
expression of sucrase-isomaltase several days after reaching confluence
(12-15). To block PI3K signaling, we used LY294002, a compound that
acts as a competitive inhibitor of the adenosine triphosphate-binding
site of PI3K and has been shown to cause specific inhibition with an
IC50 of 1.4-5 µM in intact cells (30). Daily
addition of 10 µM LY294002 beginning at confluence
strongly attenuated the expression levels of two enterocytic
differentiation markers, viz. sucrase-isomaltase and villin,
compared with untreated cells at days 3, 6, and 12 post-confluence
(Fig. 1A). Loss of PI3K
activity did not interfere with overall protein expression, as shown by
similar actin levels in LY294002-treated and untreated cells (Fig.
1A). To ascertain that the loss of differentiation marker
expression was not a consequence of increased apoptosis, we evaluated
the expression of poly(ADP-ribose) polymerase, a well known caspase-3
substrate (31), in cells treated with LY294002. As shown in Fig.
1A, chronic treatment of confluent Caco-2/15 cells with the
PI3K inhibitor had no effect on poly(ADP-ribose) polymerase cleavage,
suggesting that persistent inhibition of PI3K did not affect Caco-2/15
cell survival.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
PI3K inhibition alters functional
differentiation of human intestinal epithelial cells.
A, confluent Caco-2/15 cells (day 0) were treated daily with
(+) or without ( ) 10 µM LY294002 and harvested at days
3, 6, and 12 post-confluence. Fifty µg of cell lysate were separated
by SDS-PAGE, and proteins were analyzed by Western blotting to
determine the expression levels of sucrase-isomaltase, villin, actin,
and poly(ADP-ribose) polymerase (PARP). B,
confluent Caco-2/15 cells (day 0) were transfected with 0.1 µg of
sucrase-isomaltase reporter gene and incubated with or without 1-20
µM LY294002. The sucrase-isomaltase reporter gene vector
was also cotransfected with 0.1 µg of pcDNA3 containing or not
the dominant-negative ( p85) or constitutively active (p110*) form of
PI3K. Luciferase activity was measured 36 h after transfection.
The increase in luciferase activity was calculated relative to the
level of sucrase-isomaltase/luciferase in the untreated control, a
value set at 1. Results are the means ± S.E. of at least three
separate experiments.
|
|
The role of PI3K in sucrase-isomaltase expression was further
investigated by transient transfection of newly confluent Caco-2/15 cells with a luciferase reporter gene under the control of the human
sucrase-isomaltase promoter. As shown in Fig. 1B,
sucrase-isomaltase gene expression was inhibited in a
dose-dependent manner by the PI3K inhibitor LY294002, with
a maximal effect observed at 20 µM (91% inhibition).
Furthermore, overexpression of a dominant-negative form of the
regulatory p85 subunit ( p85) reduced sucrase-isomaltase gene
expression by 50%. Conversely, overexpression of a constitutively active p110 subunit (p110*) slightly enhanced sucrase-isomaltase gene expression.
Caco-2/15 cell cultures were characterized by transmission electron
microscopy day 14 post-confluence. As shown in Fig.
2 (panels 1, 3, and
5), post-confluent Caco-2/15 cells exhibited ultrastructural
characteristics similar to those found in the intact villus epithelium,
including well organized brush borders, terminal webs at the luminal
aspect of absorptive cells, and typical junctional complexes.
Interestingly, treatment of confluent Caco-2/15 cells with the PI3K
inhibitor remarkably affected cell polarization and brush-border
formation. Indeed, LY294002-treated cells exhibited a less polarized
and flat phenotype compared with untreated cells (Fig. 2, panels
1 and 2). The morphology of the brush border was altered markedly, as visualized by a reduction in the number of microvilli (Fig. 2, panels 3 and 4).
Interestingly, poorly defined apical junctional complexes were observed
in LY294002-treated cells (Fig. 2, panels 5 and
6). Taken together, these results indicate that PI3K
activity is necessary for functional and morphological differentiation
of intestinal epithelial cells.

View larger version (119K):
[in this window]
[in a new window]
|
Fig. 2.
PI3K inhibition alters morphological
differentiation of human intestinal epithelial cells. Caco-2/15
cells were treated from days 0 to 14 post-confluence with or without 10 µM LY294002. Cells were fixed in glutaraldehyde and
osmium tetroxide before epoxy embedding for electronic microscopy
analysis. Bars = 5 µm (panels 1 and
2), 500 nm (panels 3 and 4), and 200 nm (panels 5 and 6).
|
|
PI3K Transiently Controls Adherens Junction
Integrity--
Cell-cell adhesion plays a crucial role in the
polarization and differentiation of epithelial cells (2-4). Our
observation that LY294002-treated cells exhibited a less polarized and
differentiated phenotype as well as poorly defined apical junctions
prompted us to investigate whether PI3K might control the assembly of
adherens and tight junctions in Caco-2/15 cells. We performed
E-cadherin and ZO-1 staining in a two-step experiment in which tight
and adherens junctions of day 2 post-confluent Caco-2/15 cells were disrupted by chelating extracellular calcium and subsequently allowed
to re-establish by restoration of extracellular calcium (23, 29) in the
presence or absence of LY294002. The untreated cells showed typical
honeycomb E-cadherin and ZO-1 staining (Fig. 3A, panels 1 and
5). After a 30-min EGTA treatment, cells became rounded,
whereas E-cadherin and ZO-1 staining formed a diffuse ring at the cell
periphery (Fig. 3A, panels 2 and 6).
Following calcium restoration, E-cadherin and ZO-1 redistributed at the sites of cell-cell contact, and the cells reacquired their epithelial shape (Fig. 3A, panels 3 and 7),
suggesting that tight and adherens junctions were almost completely
reformed. However, in LY294002-treated cells, most of the
immunoreactive E-cadherin remained diffusely distributed (Fig.
3A, panel 4). Interestingly, similar results were
also noted in Caco-2/15 cells transiently transfected with the
dominant-negative mutant of p85 (Fig. 3B), indicating that PI3K inhibition interfered with the assembly of adherens junctions. This phenomenon appears to be specific for adherens junctions because
ZO-1 redistributed at the sites of cell-cell contact even in the
presence of LY294002 (Fig. 3A, panel 8).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 3.
PI3K inhibition interferes with adherens
junction assembly. A, day 1 post-confluent Caco-2/15
cell monolayers were serum-starved for 16 h and then treated with
4 mM EGTA for 30 min with (+) or without ( ) 10 µM LY294002. The EGTA-containing medium was replaced with
fresh calcium-containing medium for 30 min with or without the
inhibitor. Cells were fixed for immunofluorescence and co-stained for
E-cadherin and ZO-1 proteins. B, confluent Caco-2/15 cells
(day 0) were cotransfected with 0.5 µg of pLHCX-GFP plasmid and 0.5 µg of pcDNA3 containing or not the dominant-negative form of PI3K
( p85). One day following transfection, cells were serum-starved for
16 h and treated with 4 mM EGTA for 30 min. The
EGTA-containing medium was then replaced with fresh calcium-containing
medium for 30 min. Cells were fixed for GFP fluorescence and
immunofluorescence (IF) with anti-E-cadherin antibody.
Bar = 10 µm.
|
|
Previous studies have shown that the E-cadherin and -catenin
associated with functional adherens junctions are indirectly linked to
the cytoskeleton (32). Thus, they cannot be extracted with a solution
of 0.5% of the nonionic detergent Triton X-100, but are found in the
insoluble fraction. Inhibition of PI3K resulted in a significant
reduction in the proportion of E-cadherin and -catenin associated
with the cytoskeleton after 16-72 h of treatment in newly confluent
Caco-2/15 cells (Fig. 4A,
upper panels). Total amounts of E-cadherin or -catenin
proteins remained comparable. Interestingly, inhibition of PI3K
activity by LY294002 or by ectopic expression of the dominant-negative
mutant of p85 in newly confluent cells also led to a partial disruption
of F-actin at the periphery of the cytoplasmic membrane (Fig.
4B, right panel) and to a drastic redistribution
of total actin (Fig. 4C, right panel),
respectively; expression of GFP alone, however, did not influence actin
distribution (data not shown). It was also recently reported that the
regulation of adherens junction assembly/disassembly is dependent upon
cellular context and junction maturation (33, 34). To test the
hypothesis that PI3K activity is also important for the maintenance of
mature adherens junctions in differentiated cells, we performed Triton X-100 extraction on day 9 post-confluent cells. In this situation, PI3K
inhibition did not interfere with the association of E-cadherin or
-catenin with the cytoskeleton even after 72 h of treatment (Fig. 4A, lower panels). Overall, the results
indicate that PI3K regulates E-cadherin and -catenin association
with the cytoskeleton at the time cells reach confluence, suggesting
that PI3K activity is involved in the assembly of E-cadherin-mediated
cell-cell contacts rather than in the maintenance of mature adherens
junctions.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 4.
PI3K inhibition interferes with association
of adherens junction components with the cytoskeleton.
A: upper panels, newly confluent (day 0)
Caco-2/15 cells were treated with (+) or without ( ) 10 µM LY294002 for 3-72 h, and cells were lysed at the end
of the treatment. Lower panels, post-confluent Caco-2/15
cells were treated for 3-72 h with or without 10 µM
LY294002, and cells were lysed at the same time on day 9 post-confluence. Total cell lysates (Total) and
cytoskeleton-associated proteins (Insoluble) were separated
by SDS-PAGE and subjected to immunoblotting for E-cadherin and
-catenin. The results are representative of three independent
experiments. B: newly confluent Caco-2/15 cells (day 0) were
treated with or without 10 µM LY294002 for 48 h.
Cells were fixed for immunofluorescence (IF) and stained for
F-actin with fluorescein isothiocyanate-phalloidin. C:
confluent Caco-2/15 cells (day 0) were cotransfected with 0.5 µg of
pLHCX-GFP plasmid and 0.5 µg of pcDNA3 containing or not the
dominant-negative form of PI3K ( p85). Two days following
transfection, cells were fixed for GFP fluorescence and
immunofluorescence with anti-total actin antibody. Representative
results of in situ indirect immunofluorescence from three
independent experiments are shown in B and C. Bars = 10 µm.
|
|
PI3K Is Recruited to Adherens Junctions in Confluent
Caco-2/15 Cells--
To explore the possibility that
PI3K is recruited in response to E-cadherin engagement and acts locally
to control adherens junction formation in intestinal epithelial cells,
subconfluent (day 2), confluent (day 0), and post-confluent (day 3)
Caco-2/15 cells were double-labeled with antibodies to E-cadherin and
the p85 regulatory subunit of PI3K. As illustrated in Fig.
5A (panel 1),
expression of E-cadherin in subconfluent cells was detected at the
sites of cell-cell contact, yet a significant amount of E-cadherin was
diffusely distributed throughout the cytoplasm, which is a typical
feature of immature junctions. In the same cells, p85 staining was
restricted to the cytoplasm (Fig. 5A, panel 2),
and no significant co-localization of E-cadherin and p85 was observed
(panel 3). In newly confluent cells, E-cadherin accumulated
at cell-cell interfaces in a typical honeycomb pattern characteristic
of specialized and functional adherens junctions (Fig. 5A,
panel 4). In the same cells, p85 was still partially localized in the cytoplasm, but was also clearly visible at the sites
of cell-cell contact (Fig. 5A, panel 5, see
arrowheads) with significant co-localization of E-cadherin
and p85 (panel 6, see arrowheads). In day 3 post-confluent cells, p85 and E-cadherin were localized homogeneously
at the cell-cell interfaces (Fig. 5A, panels 7 and 8), and the superimposition of both stainings showed a
strong co-localization of these proteins (panel 9). We further studied the dynamics of E-cadherin/p85 interactions by co-immunoprecipitation assays. Fig. 5B shows that
E-cadherin/p85 association in Caco-2/15 cells was significantly
enhanced when the cells reached confluence (day 0) and further
increased at day 3 post-confluence. Taken together, these results
suggest that PI3K is recruited to E-cadherin-mediated cell-cell
contacts at the time Caco-2/15 cells reach confluence.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 5.
E-cadherin engagement recruits PI3K p85 to
the site of cell-cell contact. A,
subconfluent, confluent (day 0), and day 3 post-confluent
Caco-2/15 cells were fixed with methanol/acetone and permeabilized with
a solution of 0.1% Triton X-100 for immunofluorescence and co-staining
for PI3K p85 and E-cadherin proteins. Representative results of
in situ indirect immunofluorescence from three independent
experiments are shown. Bar = 10 µm. B,
E-cadherin and PI3K p85 were immunoprecipitated (IP) from
600 µg of lysates from subconfluent, confluent (day 0), and day 3 post-confluent Caco-2/15 cells. Proteins of the immunoprecipitates were
solubilized in Laemmli buffer and separated by SDS-PAGE. Proteins were
analyzed by Western blotting (WB) to determine the amount of
PI3K p85 and E-cadherin in the immunoprecipitates. The blots shown are
representative of three independent experiments.
-E-cadherin, anti-E-cadherin antibody.
|
|
PI3K Inhibition Interferes with Activation of Akt and p38
MAPK--
We have previously demonstrated that p38 , an isoform of
the p38 MAPK family, controls expression of some intestine-specific genes, viz. villin and sucrase-isomaltase (8). To
investigate whether PI3K and p38 MAPK act in a common or parallel
pathway in intestinal epithelial cells, we evaluated the expression and kinase activity of p38 in LY294002-treated Caco-2/15 cells. To determine the kinetics of PI3K inhibition by LY294002 in Caco-2/15 cells, we first analyzed the phosphorylation of Akt at
Ser473, which is strongly dependent upon PI3K activity
(22). As shown in Fig. 6 (upper
panels), addition of LY294002 to newly confluent Caco-2/15 cells
(day 0) did not influence Akt abundance, but strongly repressed Akt
phosphorylation throughout the treatment. In contrast, p38 MAPK
activity was inhibited only after 24, 48, and 72 h of treatment,
whereas p38 protein expression remained unaffected by the PI3K
inhibitor. This observation indicates that PI3K controls p38 MAPK
activity in intestinal epithelial cells. In contrast to Akt, however,
p38 MAPK does not seem to be a direct downstream effector of PI3K
signaling in intestinal epithelial cells.

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 6.
PI3K inhibition interferes with Akt
phosphorylation and p38 MAPK activity in newly
confluent Caco-2/15 cells. Upper panels, newly
confluent (day 0) Caco-2/15 cells were treated with (+) or without ( )
10 µM LY294002 for 3-72 h, and cells were lysed at the
end of the treatment. Lower panels, post-confluent
differentiated Caco-2/15 cells were treated for 3-72 h with or without
10 µM LY294002, and cells were lysed at the same time at
day 9 post-confluence. Cell lysates (400 µg) were immunoprecipitated
with an antibody to p38 MAPK. The levels of immunoprecipitated
p38 were analyzed by Western blotting, and the kinase activity of
p38 was demonstrated by the phosphorylation of myelin basic protein
(phospho-MBP). The phosphorylation of Akt was analyzed with
an antibody that specifically recognizes Akt phosphorylated at
Ser473 (phospho-Akt). The membrane was then
reprobed with an antibody that recognizes Akt regardless of its
phosphorylation state (total Akt). The results are
representative of three independent experiments.
|
|
As demonstrated in Fig. 4A, newly confluent Caco-2/15 cells
were more sensitive to PI3K inhibition than day 9 post-confluent cells
(differentiated cells). Therefore, we evaluated the effect of LY294002
on p38 activity in late post-confluent cells. Treatment of day 9 post-confluent Caco-2/15 cells with LY294002 did not influence p38
activity even after 72 h of treatment (Fig. 6, lower
panels), whereas Akt phosphorylation was again potently inhibited
after 3 h of LY294002 treatment (lower panels). These results indicate that PI3K controls the activation of p38 MAPK at
the time cells reach confluence and in newly confluent cells rather
than the maintenance of p38 MAPK activity in differentiated cells.
E-cadherin Engagement Leads to p38 and Akt
Activation--
We demonstrated that the kinetics of adherens junction
disruption and p38 inactivation following LY294002 treatment in
newly confluent Caco-2/15 cells were quite similar (Figs. 4A
and 6, upper panels). This observation prompted us to
investigate whether PI3K could indirectly control p38 MAPK activity
by promoting E-cadherin-dependent cell-cell interactions.
Hence, we monitored p38 activation in a calcium switch experiment
(23, 29) in the presence or absence of LY294002. Removal of calcium
from the culture medium of newly confluent Caco-2/15 cells resulted in disruption of the junctions (Fig. 3A) and clearly decreased
Akt phosphorylation and p38 MAPK activity (Fig.
7A, second lane). Interestingly, Akt phosphorylation returned to the control level 60 min
after calcium restoration, whereas p38 MAPK activity was almost
completely re-established to the control level 5 min after calcium
restoration, with an over-stimulation observed after 15 and 60 min
(Fig. 7A, third through fifth lanes).
PI3K inhibition abolished Akt phosphorylation and strongly attenuated
p38 MAPK reactivation (Fig. 7A, sixth through
eighth lanes). To verify that the modulation of Akt
phosphorylation and p38 MAPK activation was actually due to
adherens junction breakdown/reformation and not to experimental
procedure, we blocked E-cadherin engagement during calcium restoration
with an antibody known to block E-cadherin-mediated cell-cell
interaction (35). As illustrated in Fig. 7B, the use of
E-cadherin-blocking antibodies efficiently prevented Akt
phosphorylation and p38 reactivation (monitored by Western blotting
with an antibody recognizing the phosphorylated and active form of p38
MAPK) after 30 min of calcium restoration, indicating that E-cadherin
engagement was necessary for Akt and p38 MAPK activation.
Collectively, these results indicate that E-cadherin engagement
stimulates p38 and Akt pathways through a PI3K-dependent
mechanism.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
E-cadherin engagement induces
p38 MAPK and Akt activities.
A, day 2 post-confluent Caco-2/15 cell monolayers were
serum-starved for 16 h and then treated with 4 mM EGTA
for 30 min with (+) or without ( )10 µM LY294002. The
EGTA-containing medium was replaced with fresh calcium-containing
medium for 5-60 min with or without 10 µM LY294002. The
levels of immunoprecipitated p38 were analyzed by Western blotting,
and the kinase activity of p38 was demonstrated by the phosphorylation
of myelin basic protein (phospho-MBP). Akt phosphorylation
was analyzed with an antibody that specifically recognizes Akt
phosphorylated at Ser473 (phospho-Akt). The
membrane was then reprobed with an antibody that recognized Akt
regardless of its phosphorylation state (total Akt).
B, day 2 post-confluent Caco-2/15 cell monolayers were
serum-starved for 16 h and then treated with 4 mM EGTA
for 30 min with 100 µg/ml anti-E-cadherin antibody
( -E-cadherin) or mouse IgG purified from nonimmune serum.
The EGTA-containing medium was replaced with fresh calcium-containing
medium for 30 min with 100 µg/ml anti-E-cadherin antibody or mouse
IgG purified from nonimmune serum. Phosphorylation of p38 was analyzed
with a specific antibody recognizing the active phosphorylated form of
p38 (phospho-p38). Akt phosphorylation was analyzed with the
antibody that specifically recognizes Akt phosphorylated at
Ser473. The membranes were then reprobed with antibodies
recognizing total p38 and Akt, respectively. The results are
representative of three independent experiments.
|
|
 |
DISCUSSION |
Little is known regarding the mechanisms involved in the
regulation of cell growth and differentiation in the human intestinal epithelium. The data presented in this report suggest that PI3K plays a
crucial role in the control of differentiation events in this tissue.
Indeed, we have demonstrated for the first time that PI3K is part of a
signaling pathway necessary for functional and morphological
differentiation of intestinal epithelial cells. Inhibition of PI3K
decreased the expression of enterocyte markers, viz.
sucrase-isomaltase and villin, and reduced cell polarization and
brush-border formation. Furthermore, we demonstrated that E-cadherin
engagement triggers the recruitment of PI3K and activates its signaling
at the sites of cell-cell contact, and this activation appears to be
essential for the assembly of adherens junctions and the association of
their components with the cytoskeleton. Finally, we have provided
evidence that one of the molecular events resulting from
E-cadherin-mediated cellular aggregation is the activation of Akt and
p38 MAPK in a PI3K-dependent manner.
A key question in intestinal development is what triggers the
differentiation process. In this regard, it has been demonstrated that
cell-cell junction systems, particularly adherens junctions, play an important role in the control of cell differentiation during
intestinal ontogeny as well as during the continuous epithelial cell
renewal in the mature organ. For instance, studies with E-cadherin knockout mice have revealed that E-cadherin-mediated cell adhesion is
essential for the compaction of mesenchymal cells and their transition
to a polarized epithelium (3, 36). In a chimeric-transgenic animal
model, expression of a dominant-negative N/E-cadherin mutant in villous
enterocytes resulted in perturbation of cell-cell adhesion associated
with an increased enterocyte migration rate along the crypt-villus
axis, loss of the differentiated polarized phenotype, and increased
apoptosis (7). However, signaling components that relay the signal from
adherens junction proteins to the nuclear targets for the control of
intestine-specific gene expression remain elusive. Our observations
showing that PI3K was recruited to and activated by E-cadherin-mediated
cell-cell contacts in intestinal epithelial cells suggest that it may
be one of these signaling components. Such stimulation of PI3K by
E-cadherin-mediated cell-cell contacts has recently been reported in
other epithelial cell types (23, 37). Furthermore, inhibition of PI3K
activity by ectopic expression of a dominant-negative form of the
regulatory p85 subunit ( p85) or by use of the LY294002 inhibitor
repressed the expression of intestine-specific genes and delayed
functional and morphological epithelial differentiation. Inhibition of
PI3K was also found to alter adherens junction integrity in newly
confluent monolayers of Caco-2/15 cells by reducing the amount of
cytoskeleton-associated E-cadherin and -catenin at the site of
cell-cell contact. Thus, we believe that
E-cadherin-dependent PI3K activation acts as an intermediate in the formation of adherens junctions, suggesting a
bidirectional regulation between PI3K activity and adherens junction
assembly. Such bidirectional regulation has been recently described for
E-cadherin and Rac/Cdc42 (38-40). Taken together, these data indicate
that PI3K plays an important role in regulating the integrity of
adherens junctions, which in turn seems to be crucial for the efficient
differentiation of intestinal epithelial cells. The recent
demonstration that PI3K is involved in three-dimensional morphogenesis
and tissue-specific differentiation in the mammary gland (28)
strengthens this hypothesis.
The mechanism by which PI3K inhibition impairs adherens junctions is
unknown. In mammary epithelial cells, this response appears to be
mediated by changes at the level of the actin cytoskeleton (28). In
this regard, our data indeed suggest that PI3K activity regulates the
recruitment of F-actin at the site of cell-cell contact. It is known
that phosphatidylinositol 3,4,5-triphosphate, a lipid product of
PI3K, can recruit and activate the GTP exchange factor for Rac, which
is required for adherens junction formation in Madin-Darby canine
kidney cells and keratinocytes (41, 42), whereas Rac promotes the
recruitment of F-actin to these junctions (42). These observations
raise the possibility that a PI3K/Rac signaling pathway controls the
integrity of adherens junctions in intestinal epithelial cells.
However, in well polarized Caco-2/15 cells with mature intercellular
junctions, we have observed that PI3K inhibition no longer interfered
with the association of E-cadherin and -catenin with the
cytoskeleton. It is noteworthy that PI3K inhibition has no effect on
the expression of differentiation markers such as sucrase-isomaltase
and villin in well polarized Caco-2/15
cells.2 PI3K may thus act
locally to control the early establishment of E-cadherin-mediated
cell-cell contact and the initiation of the differentiation program
rather than their maintenance. These observations are consistent with
the fact that properties of E-cadherin-mediated cell-cell contact
appear to be modulated by junction maturation (33). For instance, the
regulation of E-cadherin function by Rac is progressively lost as the
E-cadherin junction matures (33, 34).
In addition to its participation in E-cadherin-mediated epithelial cell
adhesion, -catenin is a key player in the APC/Wnt signaling pathway.
In normal colonic epithelial cells, APC, in combination with
glycogen-synthase kinase-3 and axin, regulates free cytoplasmic
-catenin levels by binding to and targeting -catenin for
degradation by ubiquitination-dependent proteolysis. This
regulates the availability of free -catenin for binding with the
T-cell factor/lymphoid enhancer family of transcription factors (43).
In the absence of a Wnt signal, APC promotes the degradation of
cytoplasmic -catenin, whereas in the presence of a Wnt signal,
-catenin accumulates in the cytoplasm, translocates to the nucleus,
and coordinates with the T-cell factor/lymphoid enhancer to activate
gene transcription (44). Our observation that the inhibition of PI3K
led to a decreased association of E-cadherin and -catenin with the
cytoskeleton fraction could suggest a possible regulation of the
APC/Wnt/ -catenin signaling pathway by PI3K. However, inhibition of
PI3K activity by ectopic expression of a dominant-negative form of p85
( p85) or by use of the LY294002 inhibitor did not enhance pTOPFLASH
activity, a T-cell factor promoter/luciferase reporter plasmid that
directly assays -catenin/T-cell factor activity (45) (data not
shown). Furthermore, our data shown in Fig. 4A clearly
indicate that the total cellular amounts of -catenin protein
remained comparable following PI3K inhibition, suggesting that
-catenin was not targeted for degradation in the proteasome. Taken
together, these data suggest that PI3K does not regulate the
Wnt/ -catenin signaling pathway in newly confluent Caco-2/15 cells.
However, future studies will be needed to further clarify the
involvement of PI3K in the regulation of this pathway in intestinal
epithelial cells.
Another interesting finding from this work is the demonstration that
E-cadherin engagement led to a PI3K-dependent activation of
Akt. Akt stimulation has been involved in skeletal muscle
differentiation (46), which also depends on PI3K (19, 20). Such a
contribution of Akt to intestinal epithelial cell differentiation would
be interesting to explore. However, Akt has been implicated in the control of cell survival and thereby could mediate the protective action of E-cadherin-mediated cell-cell contacts against apoptosis (6,
37, 47).
Our study also provides evidence for the first time that
E-cadherin-mediated cell-cell contact triggers p38 MAPK cascade
activation. The p38 MAPK pathway was demonstrated previously to be
an important modulator of enterocyte differentiation (8). Thus, it
seems that PI3K and p38 MAPK act in a common pathway in intestinal epithelial cells toward the regulation of their differentiation. We
provided several indications that PI3K-dependent activation of p38 MAPK relies on the ability of PI3K to promote the assembly and integrity of adherens junctions. First, a good correlation of the
kinetics of adherens junction disruption with a decrease in p38 MAPK
activity was observed following PI3K inhibition. Second, in well
polarized cells, PI3K inhibition did not alter adherens junction
integrity or affect p38 activity. And third, PI3K inhibition, which
inhibited adherens junction but not tight junction assembly, also
attenuated E-cadherin-dependent activation of p38 .
Therefore, the ability of PI3K to control adherens junction formation
and p38 activity, known to control intestine-specific gene
transcription (8), confers to this kinase a central role in the
promotion of intestinal epithelial cell differentiation. However, the
mechanism relating PI3K to adherens junction integrity and p38 MAPK
activation remains to be elucidated.
The complexity of the PI3K-dependent pathways is further
emphasized by the recent work of Wang et al. (48), who
showed that PI3K inhibition through overexpression of PTEN (which
directly dephosphorylates the D3 phosphate group of the lipid products of PI3K) or wortmannin treatment results in an increase in alkaline phosphatase and sucrase-isomaltase enzymatic activities, suggesting a
regulatory effect of this pathway on intestinal cell differentiation. Although it cannot be excluded that these contradictory effects are the
result of the use of distinct cell lines, and they are not without
precedent (15, 49), the fact that PTEN effects were observed mostly in
the presence of butyrate is a good indication that alternative pathways
may exist.
In conclusion, migration of intestinal epithelial cells from the crypts
to the villus tips involves programming for proliferation- and
differentiation-related events. A key question in intestinal development is what triggers cell cycle arrest and the differentiation process. In vitro cell culture experiments have shown that
cell-cell contact can trigger differentiation and therefore substitute
the in vivo signal. The data presented herein indicate that
PI3K signaling plays an important role in initiating intestinal
epithelial cell differentiation. In this model (Fig.
8), E-cadherin engagement recruits and
activates PI3K signaling. This activation promotes the assembly of
adherens junction components with the cytoskeleton, which in turn
activates the p38 MAPK cascade, enhancing the transactivation capacity
of CDX2. Rac is a likely candidate as a signaling intermediate because,
as reported in other cell types, it could be a downstream effector of
PI3K (41) and an upstream activator of the p38 MAPK module (50).
However, regardless of the exact mechanism, the ability of PI3K to
control adherens junction formation and p38 MAPK activity confers to
PI3K a central role in the promotion of intestinal epithelial cell
differentiation.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 8.
Schematic of proposed pathways involved in
the regulation of functional and morphological differentiation of
intestinal epithelial cells based on the findings of this study.
In this model, E-cadherin engagement recruits and activates PI3K
signaling. This activation of PI3K might increase the amount of F-actin
at the sites of cell-cell contact (through Rac?) and thereby promote
the assembly of adherens junction components with the cytoskeleton. The
ability of PI3K to promote the assembly and integrity of adherens
junctions allows the activation of p38 MAPK, which enhances the
transactivation capacity of CDX2 for intestine-specific genes.
TJ, tight junctions; AJ, adherens junctions;
D, desmosomes; BB, brush border; W,
terminal web of actin; SI, sucrase-isomaltase.
|
|
 |
ACKNOWLEDGEMENTS |
We acknowledge the expert technical
assistance of Pierre Magny, Denis Martel, Anne Vézina, Dominique
Jean, and Claude Deschênes. We thank Elizabeth Herring and Amy
Svotelis for critical reading of the manuscript. We also acknowledge
Dr. Jacques Landry for kindly providing rabbit anti-p38 MAPK
antibody. Special thanks go to Dr. Claude Asselin for constant
encouragement, judicious comments, and excellent collaboration in the
course of this work.
 |
FOOTNOTES |
*
This work was supported by Canadian Institutes of Health
Research Grants MT-14405 and GR-15186.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Student Scholar from the Fonds de la Recherche en Santé du
Québec.
§
Scholar from the Fonds de la Recherche en Santé du
Québec. To whom correspondence should be addressed. Tel.:
819-564-5271; Fax: 819-564-5320; E-mail:
nrivard@courrier.usherb.ca.
Published, JBC Papers in Press, December 27, 2001, DOI 10.1074/jbc.M110235200
2
P. Laprise and N. Rivard, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
MAPK, mitogen-activated protein kinase;
PI3K, phosphatidylinositol 3-kinase;
ZO-1, zonula occludens-1;
PBS, phosphate-buffered saline;
GFP, green
fluorescent protein;
PIPES, 1,4-piperazinediethanesulfonic acid;
APC, adenomatous polyposis coli.
 |
REFERENCES |
| 1.
|
Babyatsky, M. W.,
and Podolsky, D. K.
(1999)
in
Growth and Development of the Gastrointestinal Tract
(Yamada, T., ed), 3rd Ed.
, pp. 547-584, J. B. Lippincott Co., Philadelphia
|
| 2.
|
Takeichi, M.
(1995)
Curr. Opin. Cell Biol.
7,
619-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Larue, L.,
Antos, C.,
Butz, S.,
Huber, O.,
Delmas, V.,
Dominis, M.,
and Kemler, R.
(1996)
Development
122,
3185-3194[Abstract]
|
| 4.
|
Vleminckz, K.,
and Kemler, R.
(1999)
Bioessays
21,
211-220[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Jou, T. S.,
Stewart, D. B.,
Stappert, J.,
Nelson, W. J.,
and Mars, J. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5067-5071[Abstract/Free Full Text]
|
| 6.
|
Hermiston, M. L.,
and Gordon, J. I.
(1995)
J. Cell Biol.
129,
489-506[Abstract/Free Full Text]
|
| 7.
|
Hermiston, M. L.,
and Gordon, J. I.
(1995)
Science
270,
1203-1207[Abstract/Free Full Text]
|
| 8.
|
Houde, M.,
Laprise, P.,
Jean, D.,
Blais, M.,
Asselin, C.,
and Rivard, N.
(2001)
J. Biol. Chem.
276,
21885-21894[Abstract/Free Full Text]
|
| 9.
|
Traber, P. G.,
and Silberg, D. G.
(1996)
Annu. Rev. Physiol.
58,
275-297[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Evers, B. M., Ko, T. C., Li, J.,
and Thompson, E. A.
(1996)
Am. J. Physiol.
271,
G722-G727[Abstract/Free Full Text]
|
| 11.
|
Deschênes, C.,
Vézina, A.,
Beaulieu, J.-F.,
and Rivard, N.
(2001)
Gastroenterology
120,
423-438[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Pinto, M.,
Robine-Leon, S.,
Appay, M. D.,
Kedinger, M.,
Triadou, N.,
Bussaulx, N.,
Lacroix, B.,
Simon-Assman, P.,
Haffen, K.,
Fogh, J.,
and Zweibaum, A.
(1983)
Biol. Cell
47,
323-330
|
| 13.
|
Vachon, P. H.,
and Beaulieu, J.-F.
(1992)
Gastroenterology
103,
414-423[Medline]
[Order article via Infotrieve]
|
| 14.
|
Peterson, M. D.,
Bement, W. M.,
and Mooseker, M. S.
(1993)
J. Cell Sci.
105,
461-472[Abstract]
|
| 15.
|
Aliaga, J. C.,
Deschênes, C.,
Beaulieu, J.-F.,
Calvo, E. L.,
and Rivard, N.
(1999)
Am. J. Physiol.
277,
G631-G641[Abstract/Free Full Text]
|
| 16.
|
Nebrada, A. R.,
and Porras, A.
(2000)
Trends Biochem. Sci.
26,
257-260
|
| 17.
|
Cuenda, A.,
and Cohen, P.
(1999)
J. Biol. Chem.
274,
4341-4346[Abstract/Free Full Text]
|
| 18.
|
Zetser, A.,
Gredinger, E.,
and Bengal, E.
(1999)
J. Biol. Chem.
274,
5193-5200[Abstract/Free Full Text]
|
| 19.
|
Chun, Y. K.,
Kim, J.,
Kwon, S.,
Choi, S. H.,
Hong, F.,
Moon, K.,
Kim, J. M.,
Choi, S. L.,
Kim, B. M.,
and Kim, S. S.
(2000)
Biochem. Biophys. Res. Comm.
276,
502-507[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Li, Y.,
Jiang, B.,
Ensign, W. Y.,
Vogt, P. K.,
and Han, J.
(2000)
Cell. Signal.
11-12,
751-757
|
| 21.
|
Rameh, L. E.,
and Cantley, L. C.
(1999)
J. Biol. Chem.
274,
8347-8350[Free Full Text]
|
| 22.
|
Datta, S. R.,
Brunet, A.,
and Greenberg, M. E.
(1999)
Genes Dev.
13,
2905-2927[Free Full Text]
|
| 23.
|
Pece, S.,
Chiariello, M.,
Murga, C.,
and Gutkind, J. S.
(1999)
J. Biol. Chem.
274,
19347-19351[Abstract/Free Full Text]
|
| 24.
|
Guay, J.,
Lambert, H.,
Gingras-Breton, G.,
Lavoie, J. N.,
Huot, J.,
and Landry, J.
(1997)
J. Cell Sci.
110,
357-368[Abstract]
|
| 25.
|
Beaulieu, J.-F.,
Nichols, B.,
and Quaroni, A.
(1989)
J. Biol. Chem.
264,
20000-20011[Abstract/Free Full Text]
|
| 26.
|
Beaulieu, J.-F.,
and Quaroni, A.
(1991)
Biochem. J.
280,
599-608
|
| 27.
|
Peterson, G. L.
(1977)
Anal. Biochem.
83,
346-356[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Somasiri, A.,
Colleen, W.,
Ellchuk, T.,
Turley, S.,
and Rosekelley, C. D.
(2000)
Differentiation
66,
116-1125[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Volberg, T.,
Geiger, B.,
Kartenbeck, J.,
and Franke, W. W.
(1986)
J. Cell Biol.
102,
1832-1842[Abstract/Free Full Text]
|
| 30.
|
Vlahos, C. J.,
Matter, W. F.,
Hui, K. Y.,
and Brown, R. F.
(1994)
J. Biol. Chem.
269,
5241-5248[Abstract/Free Full Text]
|
| 31.
|
Casciola-Rosen, L.,
Nicholson, D. W.,
Chong, T.,
Rowan, K. R.,
Thornberry, N. A.,
Miller, D. K.,
and Rosen, A.
(1996)
J. Exp. Med.
183,
1957-1964[Abstract/Free Full Text]
|
| 32.
|
Hülsken, J.,
Birchmeier, W.,
and Behrens, J.
(1994)
J. Cell Biol.
127,
2061-2069[Abstract/Free Full Text]
|
| 33.
|
Braga, V. M.,
Del Maschio, A.,
Machesky, L.,
and Dejana, E.
(1999)
Mol. Biol. Cell
10,
9-22[Abstract/Free Full Text]
|
| 34.
|
Akhtar, N.,
and Hotchin, N. A.
(2001)
Mol. Biol. Cell
12,
847-862[Abstract/Free Full Text]
|
| 35.
|
Watabe, M.,
Nagafuchi, A.,
Tsukita, S.,
and Takeichi, M.
(1994)
J. Cell Biol.
127,
247-256[Abstract/Free Full Text]
|
| 36.
|
Riethmacher, D.,
Brinkman, V.,
and Birchmeier, C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
855-859[Abstract/Free Full Text]
|
| 37.
|
Bergin, E.,
Levine, J. S.,
Koh, J. S.,
and Lieberthal, W.
(2000)
Am. J. Physiol.
278,
F758-F768[Abstract/Free Full Text]
|
| 38.
|
Braga, V. M.
(1999)
Mol. Pathol.
52,
197-202[Abstract]
|
| 39.
|
Kim, S. H.,
Zhigang, L.,
and Sacks, D. B.
(2000)
J. Biol. Chem.
275,
36999-37005[Abstract/Free Full Text]
|
| 40.
|
Nakagawa, M.,
Fukata, M.,
Yamaga, M.,
Itoh, N.,
and Kaibuchi, K.
(2001)
J. Cell Sci.
114,
1829-1838[Abstract]
|
| 41.
|
Braga, V. M.,
Machesky, L. M.,
Hall, A.,
and Hotchin, N. A.
(1997)
J. Cell Biol.
137,
1421-1431[Abstract/Free Full Text]
|
| 42.
|
Takaishi, K.,
Sasaki, T.,
Kotani, H.,
Nishioka, H.,
and Takai, Y.
(1997)
J. Cell Biol.
139,
1047-1059[Abstract/Free Full Text]
|
| 43.
|
Mimori-Kiyosue, Y.,
and Tsukita, S.
(2001)
J. Cell Biol.
154,
1105-1109[Abstract/Free Full Text]
|
| 44.
|
Ikeda, S.,
Kishida, S.,
Yamamoto, H.,
Murai, H.,
and Koyama, S.
(1998)
EMBO J.
17,
1371-1384[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Korinek, V.,
Barker, N.,
Morin, P. J.,
van Wichen, D.,
de Weger, R.,
Kinzler, K. W.,
Vogelstein, B.,
and Clevers, H.
(1997)
Science
275,
1784-1787[Abstract/Free Full Text]
|
| 46.
|
Jiang, B. H.,
Aoki, M.,
Zheng, J. Z., Li, J.,
and Vogt, P. K.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2077-2081[Abstract/Free Full Text]
|
| 47.
|
Peluso, J. J.,
Pappalardo, A.,
and Fernandez, G.
(2001)
Biol. Reprod.
64,
1183-1190[Abstract/Free Full Text]
|
| 48.
|
Wang, Q.,
Wang, X.,
Hernandez, A.,
Kim, S.,
and Evers, B. M.
(2001)
Gastroenterology
120,
1381-1392[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Taupin, D.,
and Podolsky, D. K.
(1999)
Gastroenterology
116,
1072-1080[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Zhang, S.,
Han, J.,
Sells, M. A.,
Chernoff, J.,
Knaus, U. G.,
Ulevitch, R. J.,
and Bokoch, G. M.
(1995)
J. Biol. Chem.
270,
23934-23936[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Feng, X. Sun, H. Yang, and D. H. Teitelbaum
Dissociation of E-cadherin and {beta}-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophy
J. Physiol.,
February 1, 2009;
587(3):
641 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. Wang, S. A. Keilbaugh, T. Cash-Mason, X. C. He, L. Li, and G. D. Wu
Immune-mediated signaling in intestinal goblet cells via PI3-kinase- and AKT-dependent pathways
Am J Physiol Gastrointest Liver Physiol,
November 1, 2008;
295(5):
G1122 - G1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Hu, Y. Wang, W. V. Graham, L. Su, M. W. Musch, and J. R. Turner
MAPKAPK-2 Is a Critical Signaling Intermediate in NHE3 Activation Following Na+-Glucose Cotransport
J. Biol. Chem.,
August 25, 2006;
281(34):
24247 - 24253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. P. Ramsauer, V. Pino, A. Farooq, C. A. Carothers Carraway, P. J.I. Salas, and K. L. Carraway
Muc4-ErbB2 Complex Formation and Signaling in Polarized CACO-2 Epithelial Cells Indicate That Muc4 Acts as an Unorthodox Ligand for ErbB2
Mol. Biol. Cell,
July 1, 2006;
17(7):
2931 - 2941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Thrash, C. W. Menges, R. H. Pierce, and D. J. McCance
AKT1 Provides an Essential Survival Signal Required for Differentiation and Stratification of Primary Human Keratinocytes
J. Biol. Chem.,
April 28, 2006;
281(17):
12155 - 12162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Peignon, S. Thenet, C. Schreider, S. Fouquet, A. Ribeiro, E. Dussaulx, J. Chambaz, P. Cardot, M. Pincon-Raymond, and J. Le Beyec
E-cadherin-dependent Transcriptional Control of Apolipoprotein A-IV Gene Expression in Intestinal Epithelial Cells: A ROLE FOR THE HEPATIC NUCLEAR FACTOR 4
J. Biol. Chem.,
February 10, 2006;
281(6):
3560 - 3568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-P. Gendron, S. Mongrain, P. Laprise, S. McMahon, C. M. Dubois, M. Blais, C. Asselin, and N. Rivard
The CDX2 transcription factor regulates furin expression during intestinal epithelial cell differentiation
Am J Physiol Gastrointest Liver Physiol,
February 1, 2006;
290(2):
G310 - G318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. T. Chartier, M. Laine, S. Gout, G. Pawlak, C. A. Marie, P. Matos, M. R. Block, and M. R. Jacquier-Sarlin
Laminin-5-integrin interaction signals through PI 3-kinase and Rac1b to promote assembly of adherens junctions in HT-29 cells
J. Cell Sci.,
January 1, 2006;
119(1):
31 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kim, A. J. Schein, and J. A. Nadel
E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol,
December 1, 2005;
289(6):
L1049 - L1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Y. Siu, C.-h. Wong, W. M. Lee, and C. Y. Cheng
Sertoli-Germ Cell Anchoring Junction Dynamics in the Testis Are Regulated by an Interplay of Lipid and Protein Kinases
J. Biol. Chem.,
July 1, 2005;
280(26):
25029 - 25047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hollande, A. Shulkes, and G. S. Baldwin
Signaling the Junctions in Gut Epithelium
Sci. Signal.,
March 29, 2005;
2005(277):
pe13 - pe13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Alexander and T. Ando
Density-dependent control of MAdCAM-1 and chronic inflammation. Focus on "Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells"
Am J Physiol Cell Physiol,
February 1, 2005;
288(2):
C243 - C244.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dufour, M.-J. Demers, D. Gagne, A. B. Dydensborg, I. C. Teller, V. Bouchard, I. Degongre, J.-F. Beaulieu, J. Q. Cheng, N. Fujita, et al.
Human Intestinal Epithelial Cell Survival and Anoikis: DIFFERENTIATION STATE-DISTINCT REGULATION AND ROLES OF PROTEIN KINASE B/Akt ISOFORMS
J. Biol. Chem.,
October 15, 2004;
279(42):
44113 - 44122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gonzalez, G. Tripathi, E. J. Carter, L. J. Cobb, D. A. M. Salih, F. A. Lovett, C. Holding, and J. M Pell
Akt2, a Novel Functional Link between p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Pathways in Myogenesis
Mol. Cell. Biol.,
May 1, 2004;
24(9):
3607 - 3622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Arndt, N. Suzuki, N. J. Avdi, K. C. Malcolm, and G. S. Worthen
Lipopolysaccharide-induced c-Jun NH2-terminal Kinase Activation in Human Neutrophils: ROLE OF PHOSPHATIDYLINOSITOL 3-KINASE AND Syk-MEDIATED PATHWAYS
J. Biol. Chem.,
March 19, 2004;
279(12):
10883 - 10891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Blanchard, S. Durual, M. Estienne, K. Bouzakri, M. H. Heim, N. Blin, and J.-C. Cuber
IL-4 and IL-13 Up-Regulate Intestinal Trefoil Factor Expression: Requirement for STAT6 and De Novo Protein Synthesis
J. Immunol.,
March 15, 2004;
172(6):
3775 - 3783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Laprise, A. Viel, and N. Rivard
Human Homolog of Disc-large Is Required for Adherens Junction Assembly and Differentiation of Human Intestinal Epithelial Cells
J. Biol. Chem.,
March 12, 2004;
279(11):
10157 - 10166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. I. Morin and J. Huot
Recent Advances in Stress Signaling in Cancer
Cancer Res.,
March 1, 2004;
64(5):
1893 - 1898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Okamura, T. Kimura, T. Nakano, and Y. Matsui
Cadherin-mediated cell interaction regulates germ cell determination in mice
Development,
December 29, 2003;
130(26):
6423 - 6430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Sheng, J Shao, C M Townsend jr, and B M Evers
Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells
Gut,
October 1, 2003;
52(10):
1472 - 1478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Fleet, L. Wang, O. Vitek, B. A. Craig, and H. J. Edenberg
Gene expression profiling of Caco-2 BBe cells suggests a role for specific signaling pathways during intestinal differentiation
Physiol Genomics,
March 18, 2003;
13(1):
57 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Chong, Y. J. Shin, and Y.-H. Suh
Cyclic AMP Inhibition of Tumor Necrosis Factor alpha Production Induced by Amyloidogenic C-Terminal Peptide of Alzheimer's Amyloid Precursor Protein in Macrophages: Involvement of Multiple Intracellular Pathways and Cyclic AMP Response Element Binding Protein
Mol. Pharmacol.,
March 1, 2003;
63(3):
690 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|